p38α Mitogen-Activated Protein Kinase Depletion and Repression of Signal Transduction to Translation Machinery by miR-124 and -128 in Neurons

REFERENCES

• Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, Perez L, Klein R, Nebreda AR. 2000. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell 6:109–116.
   PubMed Web of Science ®Google Scholar
• Allen M, Svensson L, Roach M, Hambor J, McNeish J, Gabel CA. 2000. Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J. Exp. Med. 191:859–870.
   PubMed Web of Science ®Google Scholar
• Mudgett JS, Ding J, Guh-Siesel L, Chartrain NA, Yang L, Gopal S, Shen MM. 2000. Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 97:10454–10459.
   PubMed Web of Science ®Google Scholar
• Tamura K, Sudo T, Senftleben U, Dadak AM, Johnson R, Karin M. 2000. Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 102:221–231.
   PubMed Web of Science ®Google Scholar
• Beardmore VA, Hinton HJ, Eftychi C, Apostolaki M, Armaka M, Darragh J, McIlrath J, Carr JM, Armit LJ, Clacher C, Malone L, Kollias G, Arthur JS. 2005. Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol. Cell. Biol. 25:10454–10464.
   PubMed Web of Science ®Google Scholar
• del Barco Barrantes I, Coya JM, Maina F, Arthur JS, Nebreda AR. 2011. Genetic analysis of specific and redundant roles for p38alpha and p38beta MAPKs during mouse development. Proc. Natl. Acad. Sci. U. S. A. 108:12764–12769.
   PubMed Web of Science ®Google Scholar
• Ono K, Han J. 2000. The p38 signal transduction pathway: activation and function. Cell. Signal. 12:1–13.
   PubMed Web of Science ®Google Scholar
• Perregaux DG, Dean D, Cronan M, Connelly P, Gabel CA. 1995. Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence. Mol. Pharmacol. 48:433–442.
   PubMed Web of Science ®Google Scholar
• Nagaleekar VK, Sabio G, Aktan I, Chant A, Howe IW, Thornton TM, Benoit PJ, Davis RJ, Rincon M, Boyson JE. 2011. Translational control of NKT cell cytokine production by p38 MAPK. J. Immunol. 186:4140–4146.
   PubMedGoogle Scholar
• Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Keys JR, Land Vatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, Young PR. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739–746.
   PubMed Web of Science ®Google Scholar
• Buxade M, Parra JL, Rousseau S, Shpiro N, Marquez R, Morrice N, Bain J, Espel E, Proud CG. 2005. The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1. Immunity 23:177–189.
   PubMed Web of Science ®Google Scholar
• Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, Clark AR, Blackshear PJ, Kotlyarov A, Gaestel M. 2006. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol. Cell. Biol. 26:2399–2407.
   PubMed Web of Science ®Google Scholar
• Pyronnet S, Imataka H, Gingras AC, Fukunaga R, Hunter T, Sonenberg N. 1999. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. EMBO J. 18:270–279.
   PubMed Web of Science ®Google Scholar
• Shveygert M, Kaiser C, Bradrick SS, Gromeier M. 2010. Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-activated protein kinase occurs through modulation of Mnk1-eIF4G interaction. Mol. Cell. Biol. 30:5160–5167.
   PubMed Web of Science ®Google Scholar
• Fukunaga R, Hunter T. 1997. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16:1921–1933.
   PubMed Web of Science ®Google Scholar
• Waskiewicz AJ, Flynn A, Proud CG, Cooper JA. 1997. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16:1909–1920.
   PubMed Web of Science ®Google Scholar
• Thomas GM, Huganir RL. 2004. MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci. 5:173–183.
   PubMed Web of Science ®Google Scholar
• Capuron L, Miller AH. 2011. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol. Ther. 130:226–238.
   PubMed Web of Science ®Google Scholar
• Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326–1331.
   PubMed Web of Science ®Google Scholar
• Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. 2010. Mechanisms underlying inflammation in neurodegeneration. Cell 140:918–934.
   PubMed Web of Science ®Google Scholar
• Neplioueva V, Dobrikova EY, Mukherjee N, Keene JD, Gromeier M. 2010. Tissue type-specific expression of the dsRNA-binding protein 76 and genome-wide elucidation of its target mRNAs. PLoS One 5:e11710. doi:10.1371/journal.pone.0011710.
   PubMedGoogle Scholar
• Famulski JK, Trivedi N, Howell D, Yang Y, Tong Y, Gilbertson R, Solecki DJ. 2010. Siah regulation of Pard3A controls neuronal cell adhesion during germinal zone exit. Science 330:1834–1838.
   PubMedGoogle Scholar
• Walters RW, Bradrick SS, Gromeier M. 2010. Poly(A)-binding protein modulates mRNA susceptibility to cap-dependent miRNA-mediated repression. RNA 16:239–250.
   PubMedGoogle Scholar
• Dobrikov M, Dobrikova E, Shveygert M, Gromeier M. 2011. Phosphorylation of eukaryotic translation initiation factor 4G1 (eIF4G1) by protein kinase Calpha regulates eIF4G1 binding to Mnk1. Mol. Cell. Biol. 31:2947–2959.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Chen C, Li Z, Guo W, Gegner JA, Lin S, Han J. 1996. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J. Biol. Chem. 271:17920–17926.
   PubMed Web of Science ®Google Scholar
• Wang XS, Diener K, Manthey CL, Wang S, Rosenzweig B, Bray J, Delaney J, Cole CN, Chan-Hui PY, Mantlo N, Lichenstein HS, Zukowski M, Yao Z. 1997. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J. Biol. Chem. 272:23668–23674.
   PubMed Web of Science ®Google Scholar
• Friedman RC, Farh KK, Burge CB, Bartel DP. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19:92–105.
   PubMed Web of Science ®Google Scholar
• Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. 2003. Prediction of mammalian microRNA targets. Cell 115:787–798.
   PubMed Web of Science ®Google Scholar
• Chi SW, Zang JB, Mele A, Darnell RB. 2009. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460:479–486.
   PubMed Web of Science ®Google Scholar
• Hendrickson DG, Hogan DJ, McCullough HL, Myers JW, Herschlag D, Ferrell JE, Brown PO. 2009. Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. PLoS Biol. 7:e1000238. doi:10.1371/journal.pbio.1000238.
   PubMed Web of Science ®Google Scholar
• Papagiannakopoulos T, Friedmann-Morvinski D, Neveu P, Dugas JC, Gill RM, Huillard E, Liu C, Zong H, Rowitch DH, Barres BA, Verma IM, Kosik KS. 2012. Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene 31:1884–1895.
   PubMed Web of Science ®Google Scholar
• Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. 2004. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 5:R13. doi:10.1186/gb-2004-5-3-r13.
   PubMed Web of Science ®Google Scholar
• Smirnova L, Grafe A, Seiler A, Schumacher S, Nitsch R, Wulczyn FG. 2005. Regulation of miRNA expression during neural cell specification. Eur. J. Neurosci. 21:1469–1477.
   PubMed Web of Science ®Google Scholar
• Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM, Farace MG. 2005. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 334:1351–1358.
   PubMed Web of Science ®Google Scholar
• Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA, Lawler S. 2008. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 68:9125–9130.
   PubMed Web of Science ®Google Scholar
• Li KK, Pang JC, Ching AK, Wong CK, Kong X, Wang Y, Zhou L, Chen Z, Ng HK. 2009. miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum. Pathol. 40:1234–1243.
   PubMed Web of Science ®Google Scholar
• Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG. 2008. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 6:14. doi:10.1186/1741-7015-6-14.
   PubMed Web of Science ®Google Scholar
• Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, Varambally S, Ghosh D, Chinnaiyan AM. 2007. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9:166–180.
   PubMed Web of Science ®Google Scholar
• Hunt S, Jones AV, Hinsley EE, Whawell SA, Lambert DW. 2011. MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. FEBS Lett. 585:187–192.
   PubMed Web of Science ®Google Scholar
• Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. 2002. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12:735–739.
   PubMed Web of Science ®Google Scholar
• Scheper GC, Morrice NA, Kleijn M, Proud CG. 2001. The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells. Mol. Cell. Biol. 21:743–754.
   PubMed Web of Science ®Google Scholar
• Dolniak B, Katsoulidis E, Carayol N, Altman JK, Redig AJ, Tallman MS, Ueda T, Watanabe-Fukunaga R, Fukunaga R, Platanias LC. 2008. Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2. J. Biol. Chem. 283:12034–12042.
   PubMedGoogle Scholar
• Tanoue T, Nishida E. 2003. Molecular recognitions in the MAP kinase cascades. Cell. Signal. 15:455–462.
   PubMed Web of Science ®Google Scholar
• Whitmarsh AJ, Davis RJ. 1998. Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. Trends Biochem. Sci. 23:481–485.
   PubMed Web of Science ®Google Scholar
• Pouyssegur J, Volmat V, Lenormand P. 2002. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochem. Pharmacol. 64:755–763.
   PubMed Web of Science ®Google Scholar
• Kovalska M, Kovalska L, Pavlikova M, Janickova M, Mikuskova K, Adamkov M, Kaplan P, Tatarkova Z, Lehotsky J. 2012. Intracellular signaling MAPK pathway after cerebral ischemia-reperfusion injury. Neurochem. Res. 37:1568–1577.
   PubMedGoogle Scholar
• Visvanathan J, Lee S, Lee B, Lee JW, Lee SK. 2007. The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev. 21:744–749.
   PubMed Web of Science ®Google Scholar
• Fabian MR, Sonenberg N, Filipowicz W. 2010. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79:351–379.
   PubMed Web of Science ®Google Scholar
• Guldal CG, Ahmad A, Korshunov A, Squatrito M, Awan A, Mainwaring LA, Bhatia B, Parathath SR, Nahle Z, Pfister S, Kenney AM. 2012. An essential role for p38 MAPK in cerebellar granule neuron precursor proliferation. Acta Neuropathol. 123:573–586.
   PubMed Web of Science ®Google Scholar
• Aouadi M, Binetruy B, Caron L, Le Marchand-Brustel Y, Bost F. 2006. Role of MAPKs in development and differentiation: lessons from knockout mice. Biochimie 88:1091–1098.
   PubMed Web of Science ®Google Scholar
• Joshi S, Sharma B, Kaur S, Majchrzak B, Ueda T, Fukunaga R, Verma AK, Fish EN, Platanias LC. 2011. Essential role for Mnk kinases in type II interferon (IFNgamma) signaling and its suppressive effects on normal hematopoiesis. J. Biol. Chem. 286:6017–6026.
   PubMed Web of Science ®Google Scholar
• Noubade R, Krementsov DN, Del Rio R, Thornton T, Nagaleekar V, Saligrama N, Spitzack A, Spach K, Sabio G, Davis RJ, Rincon M, Teuscher C. 2011. Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis. Blood 118:3290–3300.
   PubMedGoogle Scholar
• Munoz L, Ammit AJ. 2010. Targeting p38 MAPK pathway for the treatment of Alzheimer's disease. Neuropharmacology 58:561–568.
   PubMed Web of Science ®Google Scholar
• Bodles AM, Barger SW. 2005. Secreted beta-amyloid precursor protein activates microglia via JNK and p38-MAPK. Neurobiol. Aging 26:9–16.
   PubMedGoogle Scholar
• Munoz L, Ralay Ranaivo H, Roy SM, Hu W, Craft JM, McNamara LK, Chico LW, Van Eldik LJ, Watterson DM. 2007. A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model. J. Neuroinflammation 4:21. doi:10.1186/1742-2094-4-21.
   PubMed Web of Science ®Google Scholar